(68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs

Abundant expression of somatostatin receptors (SSTR) is frequently identified in differentiated neuroendocrine tumors and may serve as potential target for diagnostic imaging and treatment. This article discusses the “theranostic approach” of SSTR-targeting compounds including an overview of its rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Rudolf A., Bluemel, Christina, Allen-Auerbach, Martin S., Higuchi, Takahiro, Herrmann, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306729/
https://www.ncbi.nlm.nih.gov/pubmed/25139472
http://dx.doi.org/10.1007/s12149-014-0898-6
_version_ 1782354355786088448
author Werner, Rudolf A.
Bluemel, Christina
Allen-Auerbach, Martin S.
Higuchi, Takahiro
Herrmann, Ken
author_facet Werner, Rudolf A.
Bluemel, Christina
Allen-Auerbach, Martin S.
Higuchi, Takahiro
Herrmann, Ken
author_sort Werner, Rudolf A.
collection PubMed
description Abundant expression of somatostatin receptors (SSTR) is frequently identified in differentiated neuroendocrine tumors and may serve as potential target for diagnostic imaging and treatment. This article discusses the “theranostic approach” of SSTR-targeting compounds including an overview of its role for diagnosis, staging and restaging, discussing its way to being established in clinical routine, and giving an outlook about further potentially relevant developments.
format Online
Article
Text
id pubmed-4306729
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-43067292015-01-29 (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs Werner, Rudolf A. Bluemel, Christina Allen-Auerbach, Martin S. Higuchi, Takahiro Herrmann, Ken Ann Nucl Med Review Article Abundant expression of somatostatin receptors (SSTR) is frequently identified in differentiated neuroendocrine tumors and may serve as potential target for diagnostic imaging and treatment. This article discusses the “theranostic approach” of SSTR-targeting compounds including an overview of its role for diagnosis, staging and restaging, discussing its way to being established in clinical routine, and giving an outlook about further potentially relevant developments. Springer Japan 2014-08-20 2015 /pmc/articles/PMC4306729/ /pubmed/25139472 http://dx.doi.org/10.1007/s12149-014-0898-6 Text en © The Japanese Society of Nuclear Medicine 2014
spellingShingle Review Article
Werner, Rudolf A.
Bluemel, Christina
Allen-Auerbach, Martin S.
Higuchi, Takahiro
Herrmann, Ken
(68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title_full (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title_fullStr (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title_full_unstemmed (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title_short (68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs
title_sort (68)gallium- and (90)yttrium-/(177)lutetium: “theranostic twins” for diagnosis and treatment of nets
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306729/
https://www.ncbi.nlm.nih.gov/pubmed/25139472
http://dx.doi.org/10.1007/s12149-014-0898-6
work_keys_str_mv AT wernerrudolfa 68galliumand90yttrium177lutetiumtheranostictwinsfordiagnosisandtreatmentofnets
AT bluemelchristina 68galliumand90yttrium177lutetiumtheranostictwinsfordiagnosisandtreatmentofnets
AT allenauerbachmartins 68galliumand90yttrium177lutetiumtheranostictwinsfordiagnosisandtreatmentofnets
AT higuchitakahiro 68galliumand90yttrium177lutetiumtheranostictwinsfordiagnosisandtreatmentofnets
AT herrmannken 68galliumand90yttrium177lutetiumtheranostictwinsfordiagnosisandtreatmentofnets

Ejemplares similares